NCT02913534已完成不适用
Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy
Institut de Cancérologie de Lorraine1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年3月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Overall survival
研究概览
简要总结
The aim is to identify in patients with brain metastases the predictive factors of overall survival, survival without local recurrence and survival with progression-free brain metastases after complementary whole brain radiotherapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with one to three brain metastases treated in our department with hypofractionated stereotactic radiotherapy (SRT) from March 2008 to February 2013.
排除标准
- •A patient record captured after February 2013.
结局指标
主要结局
Overall survival
时间窗: 72 months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRTBrain Metastases, AdultNCT04805255Chang Gung Memorial Hospital135
撤回
2 期
Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain MetastasisMetastasisCancerNCT01169116Barretos Cancer Hospital
终止
1 期
Perfexion Brain MetastasisBrain MetastasesNCT00805103University Health Network, Toronto9
已完成
不适用
Diffusion-weighted MRI to Predict Treatment Response in Stereotactic Radiotherapy of Central Nervous System (CNS) MetastasesRadiotherapyBrain MetastasesSensitivityRadionecrosisNCT04700748Lund University Hospital150
已完成
不适用
Multisession Radiosurgery in Residual/Recurrent Grade II Meningiomas.Meningioma AtypicalNCT05081908Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta25